Yield of Postmortem Genetic Testing in Sudden Arrhythmic Death Syndrome: A Systematic Review and Meta-Analysis
Circulation: Genomic and Precision Medicine · 2026-06 · 19 (3)
DOI: 10.1161/circgen.125.005523 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Circulation: Genomic and Precision Medicine, 2026-06. Verfasst von Emanuele Monda und 11 weiteren Autor:innen. Beteiligte Einrichtung: Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli," Naples, Italy (E…. Hauptthemen laut MEDLINE: Arrhythmias, Cardiac, Death, Sudden, Cardiac, Genetic Testing. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 66 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Sudden arrhythmic death syndrome (SADS) refers to sudden cardiac death with structurally normal hearts at autopsy, most frequently attributed to inherited arrhythmia syndromes or concealed cardiomyopathies. Postmortem genetic testing may help identify underlying genetic causes. We aimed to investigate the yield of postmortem genetic testing in SADS cases by determining the prevalence of pathogenic or likely pathogenic variants in channelopathy- and cardiomyopathy-associated genes in autopsy-negative SADS victims. METHODS: This systematic review and meta-analysis followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and was registered in PROSPERO (REGISTRATION: URL: https://www.crd.york.ac.uk/PROSPERO/ ; Unique identifier: CRD420251067244). PubMed and Embase were searched on June 4, 2025, for observational studies including individuals aged 1 to 50 years with SADS and negative or nonspecific findings at autopsy. Eligible studies reported postmortem genetic testing for channelopathy and cardiomyopathy genes. Pathogenic or likely pathogenic variant classification followed American College of Medical Genetics and Genomics criteria and ClinGen gene-disease associations. Pooled prevalence was estimated using random-effects models. RESULTS: A total of 45 studies involving 2498 SADS cases were included. Among 1697 SADS victims tested for both channelopathy and cardiomyopathy genes (33 studies), the pooled prevalence of pathogenic or likely pathogenic variants was 11.1% (95% CI, 4.1%–26.6%, I 2 =50.7%). Testing for cardiomyopathy genes (33 studies, 1697 cases) and for channelopathy genes (42 studies, 2354 cases) yielded a prevalence of 7.0% (95% CI, 1.9%–22.9%, I 2 =51.9%) and 6.3% (95% CI, 2.0%–18.4%, I 2 =49.8%), respectively. The most frequently involved genes encoded sarcomeric proteins and ion channels, with TTN , MYBPC3 , MYH7 , KCNH2 , and SCN5A among the most commonly affected. CONCLUSIONS: Postmortem genetic testing identifies pathogenic or likely pathogenic variants in a significant subset of SADS cases, supporting its utility in postmortem evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli," Naples, Italy (E.M., M.C., E.B., G.D., G.L.).
- Health Science Interdisciplinary Center, Scuola Superiore Sant'Anna, Pisa, Italy (S.M.).
- Department of Cardiology, Cardiomyopathy Unit, Center for Cardiac Arrhythmias of Genetic Origin and Laboratory of Cardiovascular Genetics, Istituto Auxologico Italiano, IRCCS, Italy (L.C.).
- Departement of Medicine and Surgery, University Milano Bicocca, Italy (L.C.).
- Cardiovascular Pathology, Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padova, Italy (C.B.).
- IRCSS San Raffaele Roma, Cassino site, Italy (C.A.).
ORCID-Profile: Emanuele Monda, Sabrina Montuoro, Lia Crotti, Cristina Basso, Emanuele Bobbio, Camillo Autore, Elena Arbelo, Perry Mark Elliott, Eloisa Arbustini, Giuseppe Limongelli
Zitieren
APA
Monda, E., Montuoro, S., Crotti, L., Basso, C., Caiazza, M., Bobbio, E., Autore, C., Arbelo, E., Diana, G., Elliott, P. M., Arbustini, E., & Limongelli, G. (2026). Yield of Postmortem Genetic Testing in Sudden Arrhythmic Death Syndrome: A Systematic Review and Meta-Analysis. Circulation: Genomic and Precision Medicine, 19(3). https://doi.org/10.1161/circgen.125.005523
Vancouver
Monda E, Montuoro S, Crotti L, Basso C, Caiazza M, Bobbio E, et al. Yield of Postmortem Genetic Testing in Sudden Arrhythmic Death Syndrome: A Systematic Review and Meta-Analysis. Circulation: Genomic and Precision Medicine. 2026;19(3). doi:10.1161/circgen.125.005523
BibTeX
@article{Monda2026,
author = {Monda, Emanuele and Montuoro, Sabrina and Crotti, Lia and Basso, Cristina and Caiazza, Martina and Bobbio, Emanuele and Autore, Camillo and Arbelo, Elena and Diana, Gaetano and Elliott, Perry Mark and Arbustini, Eloisa and Limongelli, Giuseppe},
title = {Yield of Postmortem Genetic Testing in Sudden Arrhythmic Death Syndrome: A Systematic Review and Meta-Analysis},
journal = {Circulation: Genomic and Precision Medicine},
year = {2026},
volume = {19},
number = {3},
doi = {10.1161/circgen.125.005523}
}
EUVIMED